Gray Susannah insider trades
Gray Susannah has filed 24 Form 4s with the SEC that we hold, for MORF (Director), Theravance Biopharma, Inc. (TBPH) (Director), 4D Molecular Therapeutics, Inc. (FDMT) (Director) and Maravai Lifesciences Holdings, INC. (MRVI) (Director), among 6 companies in all. None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2021-11-23 and the latest 2026-09-24.
MORF
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Theravance Biopharma, Inc. (TBPH)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
4D Molecular Therapeutics, Inc. (FDMT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Maravai Lifesciences Holdings, INC. (MRVI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
APR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Anaptysbio, INC (ANAB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1833453) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms